Altmeyer Anne
SEC Form 4 insider trading activity
Altmeyer Anne has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company, with disclosures dating back to 2025. 3 of those filings fall inside the rolling window. Most recent filing: Jun 11, 2026.
On the most recent filing, Altmeyer Anne is listed as Director at Corbus Pharmaceuticals Holdings, Inc. Inside the rolling window, Altmeyer Anne reported no open-market purchases and 2 open-market sales totaling $41K in CRBP. The largest disclosed transaction in the window is a sale of 1,060 CRBP shares on Oct 20, 2025, worth $22K.
Companies traded
Other insiders at CRBP
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$41K
reported sales (SEC code S)
Companies
1
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Altmeyer Anne made?
Altmeyer Anne has filed 3 SEC Form 4 filings (4 transaction rows) across 1 company since 2025.
Which companies does Altmeyer Anne trade?
Altmeyer Anne has filed SEC Form 4 disclosures for 1 company, including CRBP.
When was Altmeyer Anne's most recent SEC Form 4 filing?
Altmeyer Anne's most recent SEC Form 4 filing on Tracefour is dated Jun 11, 2026.
What is Altmeyer Anne's total buy and sell value in the current window?
Inside the rolling retention window, Altmeyer Anne bought $0 and sold $41K based on SEC Form 4 filings.
What was Altmeyer Anne's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 1,060 CRBP shares on 2025-10-20, worth $22K, per SEC Form 4 filings.